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Echinococcus 
multilocularis in
Estonia 
To the Editor: Alveolar echinoco-
ccosis (AE) caused by Echinococcus
multilocularis is one of the most
important emerging zoonosis in
Europe. The fatality rate is >90% in
untreated patients (1). In Europe, the
distribution range of the zoonotic
tapeworm  E. multilocularis has
expanded over the last few decades,
and the parasite attracts increasing
awareness as a public health issue
(2–5). In 2003, AE was added to the
list of zoonoses to be monitored in the
member states of the European Union,
according to Directive 2003/99/EC.
This is the first report of E. multi-
locularis in Estonia, which extends its
northern distribution in Europe.
Results of examinations of 17 red
foxes shot in the eastern (Võnnu and
Räpina) and western (Hiiumaa) dis-
tricts of Estonia from February to
December 2003 were included in this
study. We examined the intestinal
tracts by the sedimentation and count-
ing technique as described (1).
Echinococcus adult stages were found
in 5 foxes (29.4%). Two foxes, infect-
ed with 3 and 5 adult worms, were
from the Räpina district; 2 foxes,
infected with 66 and 133 worms, were
from the Võnnu district; and 1 fox,
infected with the highest number of
worms (927), was from the Hiiumaa
District. The worms were retrieved,
counted, washed, and stored in 90%
ethanol until DNA purification. The
parasites were identified as E. multi-
locularis, based on the most important
morphometric parameters of adult
stages (length of worms, number of
proglottids, terminal proglottids in
percentage of total worm length, posi-
tion of genital pore, and form of
uterus) (2).
To confirm the taxonomic status of
the worms, polymerase chain reaction
(PCR) was conducted, followed by
restriction fragment length polymor-
phism (RFLP) analysis and direct
sequencing of a portion of the NADH
dehydrogenase subunit I (ND1) gene
of the mtDNA. A total of 6 specimens
of  E. multilocularis were used for
genetic analysis. Total genomic DNA
was extracted with the High Pure
PCR Template Preparation Kit (Roche
Molecular Biochemicals, Mannheim,
Germany) according to manufactur-
er’s instructions. PCR-RFLP was per-
formed as described by Gonzalez et
al. (6). The RFLP pattern of E. multi-
locularis isolates differed from that of
E. granulosus. Diagnostic cleavage at
the locus Eg9 of E. multilocularis
with the enzyme CfoI is able to distin-
guish E. multilocularis and its closest
relative E. granulosus (Figure, lanes 3
and 4 vs. lane 10). All 6 specimens of
E. multilocularis produced identical
results. A 426-bp fragment of the
mitochondrial ND1 gene was ampli-
fied with the primers NDfor2-
AGTTTCGTAAGGGTCCTAATA
and NDrev2-CCCACTAACTAA-
CTCCCTTTC using the BD
Advantage 2 PCR Kit (Becton
Dickinson Biosciences, Franklin
Lakes, NJ, USA) as described (7).
DNA cycle sequencing was per-
formed by using the DYEnamic ET
Terminator Cycle Sequencing Kit
(Amersham Pharmacia Biotech,
Piscataway, NJ, USA). Sequences
were resolved on an ABI PRISM 377
automated DNA sequencer (Applied
Biosystems, Foster City, CA, USA). 
All analyzed E. multilocularis
specimens had identical sequences.
The ND1 sequence of E. multilocu-
laris from Estonia was submitted to
GenBank under accession no.
AY855918. The nucleotide sequences
obtained were compared with those in
the GenBank sequence database. The
sequence of the Estonian isolate was
identical with other E. multilocularis
sequences deposited under accession
nos. AJ32907, AJ32908, AJ32909,
and AJ32910 from Poland (7) and
AY389984 from China (Yang JK et
al., unpub. data), and differed consid-
erably from the sequences of the most
closely related species, E. granulosus.
For phylogenetic analysis, the ND1
sequences of 7 E. multilocularis, 24
E. granulosus, 1 Taenia solium, 1 E.
vogeli, and 1 E. oligarthrus isolates
were included and MrBayes 3.04b (8)
was used for the Bayesian estimation
of phylogeny, applying the GTR+I+G
substitution model that best fitted the
data (determined with Modeltest 3.06)
(9). Searches were conducted with
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Figure. Diagnostic polymerase chain reaction (PCR) restriction fragment length polymor-
phism analysis for Echinococcus multilocularis (lanes 1–8, 2 specimens in parallel) and E.
granulosus (lanes 9–12, 1 specimen). Lane M: Gene Ruler 100-bp DNA ladder; lane C:
negative control without DNA; lanes 1 and 2: amplification of E. multilocularis DNA with
Eg9 PCR; lanes 3 and 4: amplification of E. multilocularis DNA with Eg9 PCR, followed by
cleavage with enzyme CfoI; lanes 5 and 6: amplification of E. multilocularis DNA with Eg9
PCR, followed by cleavage with enzyme RsaI; lanes 7 and 8: amplification of E. multiloc-
ularis DNAwith Eg16 PCR; lane 9: amplification of E. granulosus DNAwith Eg9 PCR; lane
10: amplification of E. granulosus DNA with Eg9 PCR, followed by cleavage with enzyme
CfoI; lane 11: amplification of E. granulosus DNAwith Eg9 PCR, followed by cleavage with
enzyme RsaI; lane 12: amplification of E. granulosus DNA with Eg16 PCR.LETTERS
4 simultaneous Markov chains over 2
million generations, sampled every
100 generations, and ended with a cal-
culation of a 50% majority rule con-
sensus tree. On the phylogenetic tree,
sequences of Estonian isolate group
together with those of other E. multi-
locularis isolates from different coun-
tries and were clearly separated from
those of all other species (data not
shown). The results of genetic analy-
sis confirmed morphologic identifica-
tion of E. multilocularis.
This study reports a new location
of  E. multilocularis in Europe.
Estonia is the northernmost country
on the mainland of the continent
where  E. multilocularis has been
described. Because no studies have
been published on the occurrence of
E. multilocularis in Estonia in either
foxes or rodents, whether this report
identifies a stable endemic area or
whether the parasite has expanded its
range recently cannot be determined.
Although a limited number of foxes
were examined, the occurrence of E.
multilocularis appears to be frequent
and widespread in Estonia, which
poses a risk for putatively parasite-
free adjacent countries in Fenno-
scandia.
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Influenza Virus
Infection in Racing
Greyhounds 
To the Editor: Influenza is global-
ly the most economically important
respiratory disease in humans, pigs,
horses, and fowl (1). Influenza virus is
known for its continuous genetic and
antigenic changes, which impeded
effective influenza control (1,2). More
importantly, emergence of a new sub-
type by genetic reassortment or inter-
species transmission is of great con-
cern for preventing influenza epi-
demics and pandemics (1). Recently,
influenza outbreaks have occurred in
species (feline and canine) that histor-
ically do not carry influenza virus
(3,4), which alerted both regulatory
and scientific communities to expan-
sion of the host range of influenza
virus. We report an outbreak of respi-
ratory disease by influenza virus
infection in Iowa racing greyhounds
after influenza outbreaks in Florida in
2004.
In mid-April, an influx of racing
greyhounds into Iowa greyhound
tracks resulted in outbreaks of respira-
tory disease within the track com-
pounds. The disease was character-
ized by rapid onset of fever and
cough, rapid respiration, and hemor-
rhagic nasal discharge. The illness
rate was almost 100% in both race-
track compounds, although the death
rate was <5%. Most affected dogs
recovered, yet many died of hemor-
rhagic pneumonia. Therapeutic
administration of broad-spectrum
antimicrobial drugs reduced the
severity of the disease but could not
control it.
Tissue samples from 4 animals that
died of severe pneumonia were sub-
mitted to the Iowa State University
Veterinary Diagnostic Laboratory.
The animals represented 2 different
racing tracks located in eastern and
western Iowa. On gross examination,
lungs exhibited extensive red to red-
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